Barriers in the brain: a renaissance? Trends Neurosci, pp.279-86, 2008. ,
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders, Neuron, vol.57, issue.2, pp.178-201, 2008. ,
DOI : 10.1016/j.neuron.2008.01.003
Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis, The Journal of Comparative Neurology, vol.420, issue.2, pp.236-60, 2007. ,
DOI : 10.1002/cne.21307
C-C chemokine receptor 6???regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE, Nature Immunology, vol.181, issue.5, pp.514-537, 2009. ,
DOI : 10.1002/glia.1101
Involvement of the choroid plexus in central nervous system inflammation, Microscopy Research and Technique, vol.21, issue.1, pp.112-141, 2001. ,
DOI : 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5
Immune surveillance in the central nervous system, Nature Neuroscience, vol.14, issue.8, 2012. ,
DOI : 10.1084/jem.20070885
Astrocyte???endothelial interactions at the blood???brain barrier, Nature Reviews Neuroscience, vol.15, issue.1, pp.41-53, 2006. ,
DOI : 10.1046/j.1469-7580.2002.00065.x
THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER, Annual Review of Neuroscience, vol.22, issue.1, pp.11-28, 1999. ,
DOI : 10.1146/annurev.neuro.22.1.11
Tight Junctions, Int Rev Cytol, vol.248, issue.06, pp.261-98, 2006. ,
DOI : 10.1007/3-540-29623-9_3460
Development, maintenance and disruption of the blood-brain barrier, Nature Medicine, vol.12, issue.12, pp.1584-96, 2013. ,
DOI : 10.1253/circj.CJ-11-0121
Astrocyte???neuron interactions in neurological disorders, Journal of Biological Physics, vol.5, issue.12, pp.317-353, 2009. ,
DOI : 10.1007/s10867-009-9157-9
Policing the Police: Astrocytes Modulate Microglial Activation, Journal of Neuroscience, vol.26, issue.15, pp.3887-3895, 2006. ,
DOI : 10.1523/JNEUROSCI.0936-06.2006
Pericytes regulate the blood???brain barrier, Nature, vol.57, issue.7323, pp.557-61, 2010. ,
DOI : 10.1038/nature09522
Astrocyte-endothelial interactions and blood-brain barrier permeability*, Journal of Anatomy, vol.200, issue.6, pp.629-667, 2002. ,
DOI : 10.1046/j.1469-7580.2002.00064.x
Adenosine Receptors and the Central Nervous System, Handb Exp Pharmacol, vol.193, pp.471-534, 2009. ,
DOI : 10.1007/978-3-540-89615-9_16
Adenosine Receptors and Neurological Disease: Neuroprotection and Neurodegeneration, Handb Exp Pharmacol, vol.193, pp.535-87, 2009. ,
DOI : 10.1007/978-3-540-89615-9_17
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1783, issue.5, pp.673-94, 2008. ,
DOI : 10.1016/j.bbamcr.2008.01.024
5???-Nucleotidase: molecular structure and functional aspects, Biochemical Journal, vol.285, issue.2, pp.345-65, 1992. ,
DOI : 10.1042/bj2850345
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1132794/pdf
Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors, J Pharmacol Exp Ther, vol.283, issue.3, pp.1230-1238, 1997. ,
Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices, Neurochemistry International, vol.26, issue.4, pp.387-95, 1995. ,
DOI : 10.1016/0197-0186(94)00144-J
Adenosine receptors as therapeutic targets, Nature Reviews Drug Discovery, vol.357, issue.3, pp.247-64, 2006. ,
DOI : 10.1016/S0960-894X(02)00609-1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463109
Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1808, issue.5, pp.1358-79, 2011. ,
DOI : 10.1016/j.bbamem.2010.12.018
Adenosine receptors: thera? peutic aspects for inflammatory and immune diseases, Nat Rev Drug Discovery, vol.7, issue.9, pp.759-70, 2008. ,
DOI : 10.1201/9781420005776
Interna? tional Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol Rev, vol.53, issue.4, pp.527-52, 2001. ,
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update, Pharmacological Reviews, vol.63, issue.1, pp.1-34, 2011. ,
DOI : 10.1124/pr.110.003285
Adenosine Receptor Signaling Modulates Permeability of the Blood-Brain Barrier, Journal of Neuroscience, vol.31, issue.37, pp.13272-80, 2011. ,
DOI : 10.1523/JNEUROSCI.3337-11.2011
Purinergic Signaling during Inflammation, New England Journal of Medicine, vol.367, issue.24, pp.2322-2355, 2012. ,
DOI : 10.1056/NEJMra1205750
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675791
Tissue distribution of adenosine receptor mRNAs in the rat, British Journal of Pharmacology, vol.89, issue.6, pp.1461-1469, 1996. ,
DOI : 10.1111/j.1476-5381.1996.tb15561.x
Cloning and expression of an A1 adenosine receptor from rat brain, Mol Pharmacol, vol.40, issue.1, pp.1-7, 1991. ,
Structure and function of adenosine receptors and their genes, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.362, issue.4-5, pp.4-5364, 2000. ,
DOI : 10.1007/s002100000313
Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis, Annals of Neurology, vol.56, issue.5, pp.650-658, 2001. ,
DOI : 10.1002/ana.1007
A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis, The Journal of Immunology, vol.188, issue.11, pp.5713-5735, 2012. ,
DOI : 10.4049/jimmunol.1200545
Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system, The Journal of Comparative Neurology, vol.50, issue.2, pp.163-86, 1998. ,
DOI : 10.1002/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D
Distribution of adenosine A2 receptor mRNA in the human brain, Neuroscience Letters, vol.130, issue.2, pp.177-81, 1991. ,
DOI : 10.1016/0304-3940(91)90391-6
Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study, SICI)1098?23964<322:AID?SYN6>3.0.CO;2?E, pp.322-357, 1997. ,
DOI : 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E
Adenosine enhances glial glutamate efflux via A2a adenosine receptors, Life Sciences, vol.68, issue.12, pp.1343-50, 2001. ,
DOI : 10.1016/S0024-3205(00)01036-5
Antagonistic Interaction between Adenosine A2A Receptors and Na+/K+-ATPase-??2 Controlling Glutamate Uptake in Astrocytes, Journal of Neuroscience, vol.33, issue.47, pp.18492-502, 2013. ,
DOI : 10.1523/JNEUROSCI.1828-13.2013
Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes, Glia, vol.63, issue.5, pp.702-718, 2012. ,
DOI : 10.1002/glia.22290
Adenosine-dopamine interactions: Development of a concept and some comments on therapeutic possibilities, Neurology, vol.61, issue.Issue 11, Supplement 6, pp.5-9, 2003. ,
DOI : 10.1212/01.WNL.0000095204.89871.FF
Physiological roles for ecto?5??nucleotidase (CD73) Purinergic Signal, pp.351-60, 2006. ,
Purinergic signalling and immune cells, Purinergic Signalling, vol.308, issue.Suppl 1, pp.529-64, 2014. ,
DOI : 10.1007/s11302-014-9427-2
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences, vol.105, issue.27, pp.9325-9355, 2008. ,
DOI : 10.1073/pnas.0711175105
Targeted Disruption of cd73/Ecto-5'-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response, Circulation Research, vol.95, issue.8, pp.814-835, 2004. ,
DOI : 10.1161/01.RES.0000144796.82787.6f
Human brain endothelial cells are responsive to adenosine receptor activation, Purinergic Signalling, vol.138, issue.2, pp.265-73, 2011. ,
DOI : 10.1007/s11302-011-9222-2
Mechanism of Action of IFN-beta in the Treatment of Multiple Sclerosis: A Special Reference to CD73 and Adenosine, Annals of the New York Academy of Sciences, vol.285, issue.2, pp.641-649, 2007. ,
DOI : 10.1002/eji.1830270137
A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability, Molecular Neurobiology, vol.39, issue.Pt 12, pp.10-1007, 2014. ,
DOI : 10.1517/13543780903052764
Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function, The Journal of Immunology, vol.165, issue.9, pp.5262-5270, 2000. ,
DOI : 10.4049/jimmunol.165.9.5262
Adenosine receptor signaling in the brain immune system, Trends in Pharmacological Sciences, vol.26, issue.10, pp.511-517, 2005. ,
DOI : 10.1016/j.tips.2005.08.004
Adenosine, Neuron, vol.36, issue.5, pp.855-68, 2002. ,
DOI : 10.1016/S0896-6273(02)01067-X
Modulation of glial cell functions by adenosine receptors, Physiology & Behavior, vol.92, issue.1-2, pp.15-20, 2007. ,
DOI : 10.1016/j.physbeh.2007.05.031
Involvement of astrocytes in purine-mediated reparative processes in the brain, International Journal of Developmental Neuroscience, vol.19, issue.4, pp.395-414, 2001. ,
DOI : 10.1016/S0736-5748(00)00084-8
Purinergic signalling in neuron???glia interactions, Nature Reviews Neuroscience, vol.15, issue.6, pp.423-459, 1928. ,
DOI : 10.1038/nrn1928
Adenosine A1 receptor?mediated activation of phospholipase C in cultured astro? cytes depends on the level of receptor expression, J Neurosci Off J Soc Neurosci, vol.17, issue.13, pp.4956-64, 1997. ,
CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system, Proceedings of the National Academy of Sciences, vol.109, issue.40, pp.16312-16319, 2012. ,
DOI : 10.1073/pnas.1205589109
Dichlobenil and 2,6?dichlorobenzamide (BAM) in the environ? ment: what are the risks to humans and biota? Sci Total Environ, pp.3732-3741, 2011. ,
Staurosporine-induced apoptosis in astrocytes is prevented by A1 adenosine receptor activation, Neuroscience Letters, vol.418, issue.1, pp.66-71, 2007. ,
DOI : 10.1016/j.neulet.2007.02.061
Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes, Glia, vol.89, issue.4, pp.410-418, 2004. ,
DOI : 10.1002/glia.20016
Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease, Journal of Neuroinflammation, vol.5, issue.1, pp.12-22, 2008. ,
DOI : 10.1186/1742-2094-5-12
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum, Journal of Neurochemistry, vol.107, issue.4, pp.1147-57, 2008. ,
DOI : 10.1111/j.1471-4159.2008.05697.x
Rho and Rac but not Cdc42 regulate endothelial cell permeability, J Cell Sci, vol.114, pp.1343-55, 2001. ,
In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection, Journal of Virological Methods, vol.121, issue.2, pp.171-80, 2004. ,
DOI : 10.1016/j.jviromet.2004.06.013
Structural and Functional Regulation of Tight Junctions by RhoA and Rac1 Small GTPases, The Journal of Cell Biology, vol.5, issue.1, pp.101-116, 1998. ,
DOI : 10.1083/jcb.139.4.929
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling, The FASEB Journal, vol.21, issue.13, pp.3666-76, 2007. ,
DOI : 10.1096/fj.07-8329com
Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition, Hepatology, vol.37, issue.Suppl 2, pp.185-94, 2009. ,
DOI : 10.1002/hep.22589
Adenosine Receptors: Expression, Function and Regulation, International Journal of Molecular Sciences, vol.15, issue.2, pp.2024-52, 2014. ,
DOI : 10.3390/ijms15022024
CELL BIOLOGY: Purinergic Chemotaxis, Science, vol.314, issue.5806, pp.1689-90, 2006. ,
DOI : 10.1126/science.1137190
Cell-surface enzymes in control of leukocyte trafficking, Nature Reviews Immunology, vol.17, issue.10, pp.760-71, 2005. ,
DOI : 10.1038/nri1705
Tissue-Resident Ecto-5' Nucleotidase (CD73) Regulates Leukocyte Trafficking in the Ischemic Brain, The Journal of Immunology, vol.188, issue.5, pp.2387-98, 2012. ,
DOI : 10.4049/jimmunol.1003671
CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes, The Journal of Immunology, vol.180, issue.9, pp.6288-96, 2008. ,
DOI : 10.4049/jimmunol.180.9.6288
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709497
Regulation of Leukocyte Migration Across Endothelial Barriers by ECTO-5???-Nucleotidase-Generated Adenosine, Nucleosides, Nucleotides and Nucleic Acids, vol.165, issue.6-7, pp.755-6010, 1080. ,
DOI : 10.1152/ajpcell.00132.2004
A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple Sclerosis, Journal of Neuroscience, vol.24, issue.6, pp.1521-1530, 2004. ,
DOI : 10.1523/JNEUROSCI.4271-03.2004
Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats, Brain Research, vol.1309, pp.116-141, 2010. ,
DOI : 10.1016/j.brainres.2009.10.054
The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus, The EMBO Journal, vol.9, issue.Suppl 2, pp.7-22, 2014. ,
DOI : 10.1002/embj.201386609
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion, Cell, vol.91, issue.4, pp.521-551, 1997. ,
DOI : 10.1016/S0092-8674(00)80438-9
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experi? mental autoimmune encephalomyelitis, J Neuroinflamm, vol.9, pp.193-203, 2012. ,
Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1, Cellular and Molecular Life Sciences, vol.20, issue.24, pp.4233-4281, 2010. ,
DOI : 10.1007/s00018-010-0433-4
CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein?induced experimental autoimmune encephalomyelitis: kinetics and cellular origin, Journal of Neuroinflammation, vol.2, issue.1, pp.17-27, 2005. ,
DOI : 10.1186/1742-2094-2-17
CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system, Journal of Neuroimmunology, vol.137, issue.1-2, pp.210-217, 2003. ,
DOI : 10.1016/S0165-5728(03)00085-7
CX3CR1 drives cytotoxic CD4+CD28??? T cells into the brain of multiple sclerosis patients, Journal of Autoimmunity, vol.38, issue.1, pp.10-19, 2012. ,
DOI : 10.1016/j.jaut.2011.11.006
The Chemokine Fractalkine in Patients With Severe Traumatic Brain Injury and a Mouse Model of Closed Head Injury, Journal of Cerebral Blood Flow & Metabolism, vol.115, issue.10, pp.1110-1118, 2004. ,
DOI : 10.1097/01.WCB.0000133470.91843.72
The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system, The FASEB Journal, vol.20, issue.7, pp.896-905, 2006. ,
DOI : 10.1096/fj.05-5465com
Central nervous system (CNS)???resident natural killer cells suppress Th17 responses and CNS autoimmune pathology, The Journal of Experimental Medicine, vol.6, issue.9, pp.1907-1928, 2010. ,
DOI : 10.1016/j.immuni.2009.05.001
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931174
Current Approaches for Drug Delivery to Central Nervous System, Current Drug Delivery, vol.7, issue.5, pp.389-97, 2010. ,
DOI : 10.2174/156720110793566245
Current Advances in Delivery of Biotherapeutics Across the Blood-Brain Barrier, Current Drug Discovery Technologies, vol.8, issue.2, pp.87-101, 2011. ,
DOI : 10.2174/157016311795563866
The blood-brain barrier: Bottleneck in brain drug development, NeuroRX, vol.550, issue.1, pp.3-14, 2005. ,
DOI : 10.1602/neurorx.2.1.3
Osmotic blood?brain barrier disruption: a new means of increas? ing chemotherapeutic agent delivery, Trans Am Neurol Assoc, vol.104, pp.256-60, 1979. ,
Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning, American Journal of Roentgenology, vol.141, issue.4, pp.829-864, 1983. ,
DOI : 10.2214/ajr.141.4.829
Seizure-Promoting Effect of Blood?Brain Barrier Disruption, Epilepsia, vol.17, issue.1, pp.732-774, 2007. ,
DOI : 10.1002/cncr.21220
Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport, Brain Research Bulletin, vol.60, issue.3, pp.297-306, 2003. ,
DOI : 10.1016/S0361-9230(03)00043-1
A randomized, double?blind, placebo?controlled, phase 2 study of RMP?7 in combination with carboplatin administered intrave? nously for the treatment of recurrent malignant glioma, Neuro Oncol, vol.5, issue.2, pp.96-103, 2003. ,
Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7, Experimental Neurology, vol.142, issue.1, pp.14-28, 1996. ,
DOI : 10.1006/exnr.1996.0175
Enhanced Tumor Uptake of Carboplatin and Survival in Glioma-bearing Rats by Intracarotid Infusion of Bradykinin Analog, RMP-7, Neurosurgery, vol.39, issue.1, pp.125-158, 1996. ,
DOI : 10.1097/00006123-199607000-00025
Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters, British Journal of Cancer, vol.80, issue.7, pp.964-70, 1999. ,
DOI : 10.1038/sj.bjc.6690450
Intravenous RMP?7 selectively increases uptake of carboplatin into rat brain tumors, Cancer Res, vol.56, issue.17, pp.3998-4005, 1996. ,
Intracerebroventricular Administration of Drugs, Pharmacotherapy, vol.145, issue.7, pp.832-877, 2009. ,
DOI : 10.2165/00003088-200746070-00002
MR-Guided Focused Ultrasound: A Potentially Disruptive Technology, Journal of the American College of Radiology, vol.6, issue.7, pp.510-513, 2009. ,
DOI : 10.1016/j.jacr.2009.01.004
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability, Peptides, vol.22, issue.12, pp.2329-2372, 2001. ,
DOI : 10.1016/S0196-9781(01)00537-X
NGF and anti?transferrin receptor antibody conjugate: short and long?term effects on survival of cholinergic neurons in intraocular septal transplants, J Pharmacol Exp Therap, vol.268, issue.1, pp.448-59, 1994. ,
Thera? peutic bispecific antibodies cross the blood?brain barrier in nonhu? man primates, Sci Trans Med, vol.6, issue.261, 2014. ,
Intracerebroventricular amyloid-?? antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice, Proceedings of the National Academy of Sciences, vol.106, issue.11, pp.4501-4507, 2009. ,
DOI : 10.1073/pnas.0813404106
Blood???brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review, European Journal of Pharmaceutics and Biopharmaceutics, vol.87, issue.3, pp.409-441, 2014. ,
DOI : 10.1016/j.ejpb.2014.03.012